Court Ruling Gives Sandoz Canada First Generic Pirfenidone

Two Method-Of-Use Patents Ruled Obvious By Federal Court

 
• By Dean Rudge

A favorable court ruling has allowed Sandoz Canada to launch the first generic version of Roche’s Esbriet to treat idiopathic pulmonary fibrosis.

Magnifying Canada on map
pirfenidone launch will include the Sandoz Patient Support program • Source: Shutterstock

More from Generics

More from Products